Modelling the long QT syndrome with induced pluripotent stem cells
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Cited by
Items 601–700 of 1,000
Kuusela, J., Kim, J., Räsänen, E., & Aalto‐Setälä, K. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9686-0 · Cited by 17
Nguyen, H. X., Kirkton, R. D., & Bursac, N. (2018) · Nature Protocols · doi:10.1038/nprot.2018.016 · Cited by 14
The influence of hERG1a and hERG1b isoforms on drug safety screening in iPSC-CMs
Goversen, B., Jonsson, M. K. B., van den Heuvel, N. H. L., Rijken, R., Vos, M. A., van Veen, T. A. B., & de Boer, T. P. (2019) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2019.02.003 · Cited by 14
Luo, Y., Chen, Z., Blanchette, A. D., Zhou, Y., Wright, F. A., Baker, E. S., Chiu, W. A., & Rusyn, I. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.111979 · Cited by 17
Hudson, J. E., & Zimmermann, W. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.06.011 · Cited by 14
Zhong, L., Yan, Z., Jiang, D., Weng, K., Ouyang, Y., Zhang, H., Lin, X., Xiao, C., Yang, H., Yao, J., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.325009 · Cited by 14
Townsend, C. Y., & Brown, B. S. (2013) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1016s61 · Cited by 13
Okata, S., Yuasa, S., Yamane, T., Furukawa, T., & Fukuda, K. (2013) · PubMed · Cited by 13
Human pluripotent stem cells on artificial microenvironments: a high content perspective
Viswanathan, P., Gaskell, T. L., Moens, N., Culley, O. J., Hansen, D. M., Gervasio, M. K. R., Yeap, Y. J., & Danovi, D. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00150 · Cited by 14
2D and 3D in-Vitro models for mimicking cardiac physiology
Abdelsayed, G., Ali, D., Malone, A. J., Saidi, J., Myneni, M., Rajagopal, K., Cheema, F. H., & Hameed, A. (2022) · Applications in Engineering Science · doi:10.1016/j.apples.2022.100115 · Cited by 18
Clemens, D. J., Ye, D., Wang, L., Kim, C. S. J., Zhou, W., Dotzler, S. M., Tester, D. J., Marty, I., Knollmann, B. C., & Ackerman, M. J. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.04.005 · Cited by 13
Acquired Genetic and Epigenetic Variation in Human Pluripotent Stem Cells
Kyriakides, O., Halliwell, J. A., & Andrews, P. W. (2017) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2017_22 · Cited by 14
Chien, Y., Chou, S., Chang, Y.-L., Leu, H., Yang, Y.-P., Tsai, P., Lai, Y.-H., Chen, K.-H., Chang, W., Sung, S., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051480 · Cited by 13
Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling
Zhu, D., Kong, C. S. L., Gingold, J. A., Zhao, R., & Lee, D. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_257 · Cited by 15
Sensor-free and Sensor-based Heart-on-a-chip Platform: A Review of Design and Applications
Wan, H., Gu, C., Gan, Y., Wei, X., Zhu, K., Hu, N., & Wang, P. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190207170004 · Cited by 14
The role of metabolism in directed differentiation versus trans-differentiation of cardiomyocytes
Jahng, J. W. S., Zhang, M., & Wu, J. C. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.018 · Cited by 13
Induced Pluripotent Stem Cells in Cardiovascular Research
Sinnecker, D., Dirschinger, R. J., Goedel, A., Moretti, A., Lipp, P., & Laugwitz, K. (2012) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2012_6 · Cited by 13
New approaches to establish genetic causality
McNally, E. M., & George, A. L. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.02.013 · Cited by 14
Tissue-Engineering for the Study of Cardiac Biomechanics
Ma, S. P., & Vunjak‐Novakovic, G. (2016) · Journal of Biomechanical Engineering · doi:10.1115/1.4032355 · Cited by 15
Pluripotent stem cells for target organ developmental toxicity testing
Wu, X., Chen, Y., Kreutz, A., Silver, B., & Tokar, E. J. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae037 · Cited by 13
Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research
Goedel, A., My, I., Sinnecker, D., & Moretti, A. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0828-z · Cited by 13
Optogenetic Control of Human Induced Pluripotent Stem Cell‐Derived Cardiac Tissue Models
Gruber, A., Edri, O., Glatstein, S., Goldfracht, I., Huber, I., Arbel, G., Gepstein, A., Chorna, S. V., & Gepstein, L. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.021615 · Cited by 16
Self-citationCellular Reprogramming: A New Technology Frontier in Pharmaceutical Research
Brock, A., Goh, H.-T., Yang, B., Lu, Y., Li, H., & Loh, Y. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0618-z · Cited by 12
Nissan, X., Blondel, S., & Peschanski, M. (2011) · Biochemical Society Transactions · doi:10.1042/bst20110659 · Cited by 12
Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Ye, S., Wan, X., Su, J., Patel, A., Justis, B. S., Deschênes, I., & Zhao, M. (2021) · Journal of Visualized Experiments · doi:10.3791/62206 · Cited by 14
Zhao, Z., Zang, X., Niu, K., Song, W., Wang, X., Mügge, A., Aweimer, A., Hamdani, N., Zhou, X., Zhao, Y., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105108 · Cited by 11
Ye, M., Zhang, J., Liu, J., Zhang, M., Yao, F., & Cheng, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.756213 · Cited by 13
KCNH2 encodes a nuclear-targeted polypeptide that mediates hERG1 channel gating and expression
Jain, A., Stack, O., Ghodrati, S., Sanchez-Conde, F. G., Ukachukwu, C. U., Salwi, S. M., Jiménez‐Vázquez, E. N., & Jones, D. K. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214700120 · Cited by 11
Structural analysis of hERG channel blockers and the implications for drug design
AlRawashdeh, S., Chandrasekaran, S., & Barakat, K. (2023) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2023.108405 · Cited by 11
The impact of genetics on the long QT syndrome: myth or reality?
Schwartz, P. J., & Sala, L. (2023) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001027 · Cited by 11
Tan, Y., Lu, T., Chen, Y. G., Witman, N., Yan, B., Li, Y., Liu, M., Gong, Y., Ai, X., Luo, R., et al. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10522 · Cited by 11
The role of ion channelopathies in sudden cardiac death: Implications for clinical practice
Martin, C., Huang, C. L.-H., & Matthews, G. D. K. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.783994 · Cited by 13
Current status of human pluripotent stem cell based in vitro toxicity tests
Klarić, M., Winkler, J., Vojnits, K., Meganathan, K., Jagtap, S., Enseñat‐Waser, R., Hescheler, J., Sachinidis, A., & Bremer‐Hoffmann, S. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s361 · Cited by 13
Human Pluripotent Stem Cells for Genetic Disease Modeling and Drug Screening
Gauthier, M., Maury, Y., Peschanski, M., & Martinat, C. (2011) · Regenerative Medicine · doi:10.2217/rme.11.46 · Cited by 11
Šarić, T., Halbach, M., Khalil, M., & Er, F. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.863275 · Cited by 14
Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells
Garreta, E., Gonzãlez, F., & Montserrat, N. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000480710 · Cited by 13
Investigating pediatric disorders with induced pluripotent stem cells
Durbin, M. D., Cadar, A. G., Chun, Y. W., & Hong, C. C. (2018) · Pediatric Research · doi:10.1038/s41390-018-0064-2 · Cited by 12
Modeling the Response of Heart Muscle to Mechanical Stimulation In Vitro
Guo, J., & Huebsch, N. (2020) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-020-00007-8 · Cited by 12
Leinonen, J., Emanuelov, A. K., Wolf, Y., Milgrom-Hoffman, M., Lichtstein, D., Hoss, S., Lotan, C., Tzahor, E., Jung, S., & Beeri, R. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.040 · Cited by 11
iPS Cell–Derived Cardiogenicity is Hindered by Sustained Integration of Reprogramming Transgenes
Martinez‐Fernandez, A., Nelson, T. J., Reyes, S., Alekseev, A. E., Secreto, F. J., Pérez-Terzic, C. M., Beraldi, R., Sung, H., Nagy, A., & Terzic, A. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000298 · Cited by 12
Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy
Lee, Y.-K., Jiang, Y., Ran, X., Lau, Y., Ng, K., Lai, W., Siu, C., & Tse, H. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0401-5 · Cited by 14
Moreau, A., Boutjdir, M., & Chahine, M. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0726 · Cited by 11
Lieu, D. K., Turnbull, I. C., Costa, K. D., & Li, R. A. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.06.002 · Cited by 12
Stem cell‐derived cardiomyocyte heterogeneity confounds electrophysiological insights
Clark, A. P., Krogh‐Madsen, T., & Christini, D. J. (2024) · The Journal of Physiology · doi:10.1113/jp284618 · Cited by 12
Mashali, M. A., Deschênes, I., & Saad, N. S. (2025) · Children · doi:10.3390/children12060669 · Cited by 10
Arrhythmogenic Risk in iPSC-Derived Cardiomyocytes: Current Limitations and Therapeutic Perspectives
Shahannaz, D. C., Sugiura, T., Ferrell, B. E., & Yoshida, T. (2025) · Medicina · doi:10.3390/medicina61112056 · Cited by 12
Harmer, S. C., & Tinker, A. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0306 · Cited by 10
Carvalho, A. B., Coutinho, K. C. D. S., Barbosa, R. A. Q., de Campos, D. B. P., Leitão, I. D. C., Pinto, R. S., dos Santos, D. S., Farjun, B., Araujo, D. S., Mesquita, F., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1077069 · Cited by 10
Firas, J., Liu, X., Nefzger, C. M., & Polo, J. M. (2014) · Differentiation · doi:10.1016/j.diff.2014.05.003 · Cited by 10
Pluripotent Stem Cell-Derived Pancreatic β-Cells: Potential for Regenerative Medicine in Diabetes
Kao, D.-I., & Chen, S. (2012) · Regenerative Medicine · doi:10.2217/rme.12.27 · Cited by 10
Pooria, A., Pourya, A., & Gheini, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28330 · Cited by 10
Qian, T., Gil, D. A., Guzman, E. C., Gastfriend, B. D., Tweed, K. E., Palecek, S. P., & Skala, M. C. (2020) · Lab on a Chip · doi:10.1039/d0lc00546k · Cited by 10
Hancox, J. C., Stuart, G., & Harmer, S. C. (2020) · Journal of Congenital Cardiology · doi:10.1186/s40949-020-00037-9 · Cited by 10
Effects of Mexiletine on a Race-specific Mutation in Nav1.5 Associated With Long QT Syndrome
Xin, W., Li, Y., & Hong, L. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.904664 · Cited by 12
Zhao, S. R., Mondéjar‐Parreño, G., Li, D., Shen, M., & Wu, J. C. (2022) · Journal of Visualized Experiments · doi:10.3791/64265 · Cited by 12
Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells
Yanovsky‐Dagan, S., Mor‐Shaked, H., & Eiges, R. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i5.823 · Cited by 11
Human Stem Cells for Craniomaxillofacial Reconstruction
Jalali, M., Kirkpatrick, W. N. A., Cameron, M. G., Pauklin, S., & Vallier, L. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0576 · Cited by 11
iPSC for Dental Tissue Regeneration
Hynes, K., Gronthos, S., & Bartold, P. M. (2014) · Current Oral Health Reports · doi:10.1007/s40496-013-0001-8 · Cited by 10
Uses of cardiomyocytes generated from induced pluripotent stem cells
Lu, T., & Yang, L. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt85 · Cited by 10
Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy
Crombie, D. E., Pera, M. F., Delatycki, M. B., & Pébay, A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.040 · Cited by 11
Stem Cell Studies in Cardiovascular Biology and Medicine: A Possible Key Role of Macrophages
Kawaguchi, N., & Nakanishi, T. (2022) · Biology · doi:10.3390/biology11010122 · Cited by 13
Song, Y., Guo, T., Jiang, Y., Zhu, M., Wang, H., Lu, W., Jiang, M., Qi, M., Lan, F., & Cui, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02964-3 · Cited by 9
Florido, M. H. C., & Ziats, N. P. (2024) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37669 · Cited by 9
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery
Sen, C. K., Friday, A. J., & Roy, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100077 · Cited by 11
Pluripotent Stem Cells as a Platform for Cardiac Arrhythmia Drug Screening
Leyton-Mange, J. S., & Milan, D. J. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0334-1 · Cited by 10
Induced pluripotent stem cell technology and inherited arrhythmia syndromes
Ross, S. B., Fraser, S. T., & Semsarian, C. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.08.013 · Cited by 10
Use of Hipsc to Explicate Genomic Predisposition to AnthrAcycline-Induced Cardiotoxicity
Magdy, T., & Burridge, P. W. (2021) · Pharmacogenomics · doi:10.2217/pgs-2020-0104 · Cited by 10
Babini, H., Jiménez-Sábado, V., Stogova, E., Arslanova, A., Butt, M., Dababneh, S., Asghari, P., Moore, E. D. W., Claydon, T. W., Chiamvimonvat, N., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1298007 · Cited by 10
Human Genomics in Cardiovascular Medicine: Implications and Perspectives
Morita, H. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0126 · Cited by 9
Szebényi, K., Erdei, Z., Péntek, A., Sebe, A., Orbán, T. I., Sarkadi, B., & Apáti, Á. (2011) · Personalized Medicine · doi:10.2217/pme.11.19 · Cited by 13
iPCS Cell Modeling of Inherited Cardiac Arrhythmias
Shinnawi, R., & Gepstein, L. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0331-4 · Cited by 11
Self-citationDisease modeling of cardiac arrhythmias using human induced pluripotent stem cells
Liang, W., Gasparyan, L., Alqarawi, W., & Davis, D. R. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1575359 · Cited by 11
Zanella, F., & Sheikh, F. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_172 · Cited by 12
ERG1 plays an essential role in rat cardiomyocyte fate decision by mediating AKT signaling
Wang, D., Liu, C., Liu, H., Meng, Y., Lin, F., Gu, Y., Wang, H., Shang, M., Tong, C., Sachinidis, A., et al. (2021) · Stem Cells · doi:10.1002/stem.3328 · Cited by 9
Modeling CVD in Human Pluripotent Cells by Genome Editing
Hajjar, R. J., & Hulot, J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.005 · Cited by 9
Searching for new cardiovascular drugs: towards improved systems for drug screening?
Silvester, N. C., & George, C. H. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.625652 · Cited by 8
Chemical genetics and its potential in cardiac stem cell therapy
Vieira, J. M., & Riley, P. R. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01928.x · Cited by 9
Maury, Y., Gauthier, M., Peschanski, M., & Martinat, C. (2011) · médecine/sciences · doi:10.1051/medsci/2011274023 · Cited by 8
Induced pluripotent stem cell-derived cardiomyocytes: A platform for testing for drug cardiotoxicity
Bernstein, D. (2017) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2017.07.001 · Cited by 8
Wei, H., Wu, J., & Liu, Z. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7362-0_2 · Cited by 9
Wehbe, Z., Ghanjati, F., & Flotho, C. (2021) · Cells · doi:10.3390/cells10092335 · Cited by 8
The genetics of pro‐arrhythmic adverse drug reactions
Petropoulou, E., Jamshidi, Y., & Behr, E. R. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12208 · Cited by 10
New iPSC for old long QT syndrome modeling: Putting the evidence into perspective
Li, G., Cheng, G., Wu, J., Ma, S., & Sun, C. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213514000 · Cited by 8
Modeling of osteosarcoma with induced pluripotent stem cells
Pang, L. K., Pena, M., Zhao, R., & Lee, D. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102006 · Cited by 10
Human Pluripotent Stem Cells Go Diabetic: A Glimpse on Monogenic Variants
Heller, S., Melzer, M. K., Azoitei, N., Julier, C., & Kleger, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.648284 · Cited by 8
Regulatory aspects of small molecule drugs for heart regeneration
Rodgers, K. E., Papinska, A., & Mordwinkin, N. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.06.013 · Cited by 8
Tokuyama, T., Ahmed, R. E., Chanthra, N., Anzai, T., & Uosaki, H. (2021) · Biology · doi:10.3390/biology10100981 · Cited by 10
Newer designs in foot-wear for leprosy patients.
Kulkarni, V., Antia, N. H., & Mehta, J. M. (1990) · PubMed · Cited by 11
Liebau, S., Kleger, A., Levin, M. G., & Yu, S. P. (2013) · Stem Cells International · doi:10.1155/2013/238635 · Cited by 8
The Promise and Therapeutic Potential of Human ES and iPS Cells
Lu, S., Lee, R. J., Napoli, C., Oh, S. K. W., Kimbrel, E. A., & Feng, Q. (2011) · Stem Cells International · doi:10.4061/2011/959275 · Cited by 8
The Unstoppable Attraction for Induced Pluripotent Stem Cells
Gnecchi, M., & Schwartz, P. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.019 · Cited by 9
Sobitov, I., Ritzenhoff, K., Gaulrapp, M., Becker, L., Liutkute, A., Seibertz, F., Fakuade, F. E., Mason, F. E., & Voigt, N. (2025) · The Journal of Physiology · doi:10.1113/jp287545 · Cited by 7
Wu, H., Hamilton, C., Porritt, H., Winbo, A., & Zeltner, N. (2024) · The Journal of Physiology · doi:10.1113/jp286416 · Cited by 7
Cell and gene therapy for arrhythmias: Repair of cardiac conduction damage
Yong-Fu, X. (2011) · 老年心脏病学杂志:英文版 · doi:10.3724/sp.j.1263.2011.00147 · Cited by 7
Emerging model in anesthetic developmental neurotoxicity: human stem cells.
Bai, X., & Bosnjak, Z. J. (2013) · PubMed · Cited by 7
cAMP-PKA signaling modulates the automaticity of human iPSC-derived cardiomyocytes
Mazgaoker, S., Weiser-Bitoun, I., Brosh, I., Binah, O., & Yaniv, Y. (2022) · The Journal of General Physiology · doi:10.1085/jgp.202213153 · Cited by 8
Stem cells in pediatric cardiology
Patel, P., & Mital, S. R. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-012-1920-4 · Cited by 8
Barbaric, I., Allison, T. F., Powles-Glover, N. S., Biga, V., & Andrews, P. W. (2015) · International Journal of High Throughput Screening · doi:10.2147/ijhts.s58113 · Cited by 9
Jones, A. R. C., Edwards, D. H., Cummins, M. J., Williams, A. J., & George, C. H. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00089 · Cited by 7
Salazar-Noratto, G. E., Barry, F., & Guldberg, R. E. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02645h · Cited by 7
Metadata
- Authors
- Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., & Gepstein, L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gepstein, Lior
- Venue
- Nature
- Published
- 2011-01-16
- Volume
- 471
- Issue
- 7337
- Pages
- 225-229
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2115644752
- Cited by
- 1,049
- References
- 28
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 46 · 2023: 27 · 2022: 53 · 2021: 68 · 2020: 47 · 2019: 55 · 2018: 60 · 2017: 71 · 2016: 87 · 2015: 97 · 2014: 84 · 2013: 111 · 2012: 123
- FWCI
- 86.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, KCNH2 mutation, induced pluripotent stem cells, iPSC-derived cardiomyocytes, action potential duration prolongation, drug screening, drug-induced arrhythmia, sudden cardiac death, calcium channel blockers, KATP channel openers, potassium channel blockers, arrhythmogenicity
- MeSH terms
- ERG1 Potassium Channel, Adult, Cells, Cultured, Drug Evaluation, Preclinical, Female, Fibroblasts, Humans, Long QT Syndrome, Models, Biological, Phenotype, Patch-Clamp Techniques, Mutation, Missense, Myocytes, Cardiac, Ether-A-Go-Go Potassium Channels, Embryonic Stem Cells, Cell Transdifferentiation, Induced Pluripotent Stem Cells, Precision Medicine, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.